Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,249 Cr
up ₹110 Cr vs Oct 2024
- Stocks held
- 29
- unchanged
- Top 10 weight
- 63.9%
- of the portfolio in its ten largest
- Cash & debt
- 4.8%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 12
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In November 2024 it disclosed 29 stocks worth ₹3,249 Cr, up ₹110 Cr from Oct 2024. Its largest positions were Sun Pharmaceutical Industries Limited (10.3%), Suven Pharmaceuticals Limited (10.0%), Cipla Limited (7.9%); the ten largest together made up 63.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 64.2% of its equity. Cash and debt stood at 4.8%. Compared with Oct 2024 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
71%
Holds more cash than 71% of peers
Holdings in November 2024
Download CSVEvery line the fund disclosed, with the change against Oct 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 10.28%
- Δ weight
- down 0.77 pts
- Value
- ₹334 Cr
- Δ value
- down ₹12.8 Cr
- Status
- Trimmed
- Weight
- 10.01%
- Δ weight
- down 0.82 pts
- Value
- ₹325 Cr
- Δ value
- down ₹14.6 Cr
- Status
- Trimmed
- Weight
- 7.86%
- Δ weight
- up 1.00 pts
- Value
- ₹255 Cr
- Δ value
- up ₹40.2 Cr
- Status
- Added
- Weight
- 7.62%
- Δ weight
- down 0.50 pts
- Value
- ₹247 Cr
- Δ value
- down ₹7.4 Cr
- Status
- Trimmed
- Weight
- 5.98%
- Δ weight
- up 0.69 pts
- Value
- ₹194 Cr
- Δ value
- up ₹28.2 Cr
- Status
- Added
- Weight
- 5.23%
- Δ weight
- down 0.16 pts
- Value
- ₹170 Cr
- Δ value
- up ₹83 L
- Status
- Held
- Cash, TREPS & receivables
- Weight
- 4.81%
- Δ weight
- up 2.09 pts
- Value
- ₹156 Cr
- Δ value
- up ₹70.9 Cr
- Status
- Added
- Weight
- 4.79%
- Δ weight
- down 0.33 pts
- Value
- ₹155 Cr
- Δ value
- down ₹5.2 Cr
- Status
- Trimmed
- Weight
- 4.40%
- Δ weight
- up 0.07 pts
- Value
- ₹143 Cr
- Δ value
- up ₹7.1 Cr
- Status
- Added
- Weight
- 3.91%
- Δ weight
- down 0.25 pts
- Value
- ₹127 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 3.82%
- Δ weight
- up 0.42 pts
- Value
- ₹124 Cr
- Δ value
- up ₹17.4 Cr
- Status
- Added
- Weight
- 3.66%
- Δ weight
- up 0.42 pts
- Value
- ₹119 Cr
- Δ value
- up ₹17.1 Cr
- Status
- Added
- Weight
- 3.39%
- Δ weight
- up 1.18 pts
- Value
- ₹110 Cr
- Δ value
- up ₹40.8 Cr
- Status
- Added
- Weight
- 3.18%
- Δ weight
- up 0.73 pts
- Value
- ₹103 Cr
- Δ value
- up ₹26.3 Cr
- Status
- Added
- Weight
- 2.66%
- Δ weight
- down 0.21 pts
- Value
- ₹86.5 Cr
- Δ value
- down ₹3.6 Cr
- Status
- Trimmed
- Weight
- 2.65%
- Δ weight
- up 0.11 pts
- Value
- ₹86 Cr
- Δ value
- up ₹6.4 Cr
- Status
- Added
- Weight
- 2.53%
- Δ weight
- down 0.12 pts
- Value
- ₹82.2 Cr
- Δ value
- down ₹88 L
- Status
- Trimmed
- Weight
- 2.36%
- Δ weight
- up 0.02 pts
- Value
- ₹76.6 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 1.90%
- Δ weight
- down 0.05 pts
- Value
- ₹61.8 Cr
- Δ value
- up ₹61 L
- Status
- Added
- Weight
- 1.44%
- Δ weight
- down 0.13 pts
- Value
- ₹46.8 Cr
- Δ value
- down ₹2.5 Cr
- Status
- Trimmed
- Weight
- 1.38%
- Δ weight
- down 0.09 pts
- Value
- ₹44.9 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
- Weight
- 1.25%
- Δ weight
- up 0.04 pts
- Value
- ₹40.7 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 1.04%
- Δ weight
- down 0.09 pts
- Value
- ₹33.8 Cr
- Δ value
- down ₹1.7 Cr
- Status
- Trimmed
- Weight
- 0.98%
- Δ weight
- up 0.02 pts
- Value
- ₹31.7 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.69%
- Δ weight
- up 0.01 pts
- Value
- ₹22.4 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.65%
- Δ weight
- down 0.04 pts
- Value
- ₹21.1 Cr
- Δ value
- down ₹51 L
- Status
- Trimmed
- Weight
- 0.51%
- Δ weight
- down 3.34 pts
- Value
- ₹16.4 Cr
- Δ value
- down ₹104 Cr
- Status
- Trimmed
- Weight
- 0.46%
- Δ weight
- up 0.05 pts
- Value
- ₹15 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 0.45%
- Δ weight
- up 0.04 pts
- Value
- ₹14.6 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 0.08%
- Δ weight
- up <0.01 pts
- Value
- ₹2.4 Cr
- Δ value
- up ₹16 L
- Status
- Added
- Weight
- 0.04%
- Δ weight
- up 0.01 pts
- Value
- ₹1.3 Cr
- Δ value
- up ₹29 L
- Status
- Added
What changed, Oct 2024 to Nov 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Laurus Labs Limitedup ₹40.8 Cr (+1.18% pts)
- Cipla Limitedup ₹40.2 Cr (+1.00% pts)
- Globus Medical Incup ₹28.2 Cr (+0.69% pts)
- Indoco Remedies Limitedup ₹26.3 Cr (+0.73% pts)
- Concord Biotech Limitedup ₹17.4 Cr (+0.42% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Oct 2024, the weight rose most in Healthcare Equipment & Supplies (+1.0 pts) and Pharmaceuticals (+0.9 pts), and fell most in Pharmaceuticals & Biotechnology (−2.2 pts).
- Healthcare Equipment & Supplies8.1% → 9.1%+1.0 pts
- Pharmaceuticals5.6% → 6.4%+0.9 pts
- Healthcare Services18.0% → 18.3%+0.3 pts
- Pharmaceuticals & Biotechnology66.4% → 64.2%−2.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Nov 2021 | Nov 2023 | May 2024 | Aug 2024 | Oct 2024 | Nov 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 56.3% | 73.5% | 68.5% | 67.9% | 66.4% | 64.2% |
| Healthcare Services | 29.0% | 12.0% | 15.3% | 15.9% | 18.0% | 18.3% |
| Healthcare Equipment & Supplies | 5.8% | 6.1% | 8.3% | 8.3% | 8.1% | 9.1% |
| Pharmaceuticals | 6.4% | 5.7% | 5.6% | 5.6% | 5.6% | 6.4% |
| Insurance | 2.5% | 1.9% | 1.7% | 1.9% | 1.5% | 1.5% |
| Retailing | — | 0.8% | 0.6% | 0.5% | 0.4% | 0.5% |
Allocation in Nov 2024change vs Oct 2024
- Pharmaceuticals & Biotechnology (14)64.2%▼ 2.2 pts
- Healthcare Services (8)18.3%▲ 0.3 pts
- Healthcare Equipment & Supplies (2)9.1%▲ 1.0 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Nov 2024
4.8%
▲ 2.1 pts vs Oct 2024
- Cash alone
- 4.8%
- cash and net receivables
- A year earlier
- 2.3%
- Nov 2023 · now ▲ 2.5 pts
- Last 12 months
- 0.9% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.